via The Daily of the University of Washington
Welcome to part four in the the saga of generic Concerta drug substitutions. The information in part three (part two and part one for those just joining us) raised several questions about pharmacy-level processes for generics that today’s column will start to answer. But first, a little housekeeping from last time.
Continue reading “Stigma, mental health, and U(W): generic gaslighting part four”
Sarah Corn 
You must be logged in to post a comment.